Qualifying the market in an online world
Posted 28th April 2011 in Articles, Commercial, Interviews | Register to comment
With so many ways to virtually connect, does offline research still have a place in pharma? Vishal Jhanjee talks to pharmaphorum about the future for online qualitative studies.
As an industry, pharma has always placed a heavy emphasis on the power of market research studies to help it understand the market place…
Read the full articlePublic and patient involvement at NICE: why does this matter?
Posted 19th April 2011 in Articles, Interviews | Register to comment
Leela Barham shares her views on why patient and public involvement is so important in NICE decision making.
The National Institute for Health and Clinical Excellence (NICE) is the arms-length National Health Service (NHS) agency that…
Read the full articleSocial pharma faces: Matt Lowe
Posted 18th April 2011 in Articles, General, Interviews | Register to comment
In part three of our social pharma faces series we speak to Matt Lowe from Grünenthal to hear the internal perspective on how companies can use the digital space.
So far in our series of interviews we have heard from two social media experts working on the consulting / agency side of the industry…
Read the full articleSocial media guidelines: mapping the lines of the playing field
Posted 30th March 2011 in Articles, General, Interviews | 1 comment
As pharma employees use social media more for work and play, pharmaphorum spoke with Sabine Kostevc of Roche to hear how they can do so safely within the rules.
Social media is by its very definition a way of connecting with other people and presenting your views to the broader world. Over the last five years…
Read the full articleSocial pharma faces: Ángel González
Posted 23rd March 2011 in Articles, General, Interviews | Register to comment
In the second part of our interview series with key people in pharma social media, pharmaphorum looks to Spain and Ángel González for his observations.
The advertising model for pharma is changing with the growth of the digital world and the increasing power of the patient. No longer …
Read the full articleRIP big pharma drug development?
Posted 9th March 2011 in Articles, General, Interviews | Register to comment
Is the current big pharma drug development model dead and buried or just resting? pharmaphorum speaks with international expert Dr Kenneth Kaitin for some answers.
In years gone by the drug development process seemed to function like a well-oiled machine, with investment fuelling the research at one end of…
Read the full articlePatients can inspire the industry to innovate
Posted 4th March 2011 in Articles, General, Interviews | Register to comment
Can patient communities provide useful information directly to pharma and not just each other? Brian Loew, Founder of Inspire, explains to pharmaphorum how they can.
As information becomes much more readily available and patients are able to connect with each other through social networks, many disease areas…
Read the full articleSocial pharma faces: Gary Monk (part I)
Posted 23rd February 2011 in Articles, General, Interviews | Register to comment
As the first piece in a new series of interviews with some key people in pharma social media, pharmaphorum managed to catch up with Gary Monk for his observations.
Pharma is slowly learning to embrace the digital world as a new means to communicate with healthcare providers, payers and even patients…
Read the full articleCardiovascular prevention is better than a cure
Posted 14th February 2011 in Articles, General, Interviews | Register to comment
Is it in pharma’s best interest to help with cardiovascular disease prevention? In our latest interview, Professor Neil Poulter explains how it might well be.
With limited early warning signs and increasingly poor diets and lifestyles, cardiovascular disease has become a real public health issue…
Read the full articlePsoriasis 360: how pharma can do social media
Posted 7th February 2011 in Articles, General, Interviews | 1 comment
Is it time for pharma to stop pondering social media and actually dive in? Alex Butler explains how Janssen launched Psoriasis 360 and lived to tell the tale.
It seems like everyone is talking about social media and how a new paradigm has been set for the way in which businesses communicate with…
Read the full article